My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

NeuroBo Pharmaceuticals, Inc. - Common Stock (NQ:NRBO)

2.360 UNCHANGED

Last Price Updated: 3:59 PM EST, Nov 27, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about NeuroBo Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

S&P 500 Rises 1%, InMed Pharmaceuticals Shares Spike Higher ↗

September 12, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Monday.

Via Benzinga

NeuroBo (NRBO) Stock Soars 125% on Reverse Stock Split News ↗

September 12, 2022

Most of the time, a reverse stock split is bad news. But for investors in NeuroBo and NRBO stock today, this news is being cheered.

Via InvestorPlace

Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session ↗

September 12, 2022

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.

Via Benzinga

Dow Jumps 250 Points; Crude Oil Rises Over 1% ↗

September 12, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 250 points on Monday.

Via Benzinga

What In The World Is Going On With Neurobo Pharmaceuticals Shares? ↗

September 12, 2022

Neurobo Pharmaceuticals Inc (NASDAQ: NRBO) shares are trading higher by 77.04% to $0.49 Monday morning after the company announced a 1-for-30 reverse stock split.

Via Benzinga

Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday ↗

September 01, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 31, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

August 03, 2022

Wednesday's session saw 51 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 20, 2022

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The company's market cap stands at $16.7 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 15, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 08, 2022

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 05, 2022

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 14.5% to $0.53 during Tuesday's after-market session. The company's market cap stands at $14.0 million.

Via Benzinga

Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session ↗

June 24, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.

Via Benzinga

Zendesk, CalAmp, + 20 Stocks Moving In Friday's Pre-Market Session ↗

June 24, 2022

Gainers ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 58% to $2.75 in pre-market trading after jumping 26% on Thursday. ToughBuilt Industries reported closing of $6 million public offering.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 23, 2022

Via Benzinga

24 Stocks Moving in Tuesday's Pre-Market Session ↗

June 21, 2022

Gainers Valneva SE (NASDAQ: VALN) shares rose 83.6% to $25.18 in pre-market trading following Pfizer agreement to acquire an 8.1% stake.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 31, 2022

Via Benzinga

88 Biggest Movers From Yesterday ↗

May 27, 2022

Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 26, 2022

Via Benzinga

77 Stocks Moving In Tuesday's Mid-Day Session ↗

May 10, 2022

Gainers

Via Benzinga

30 Stocks Moving in Tuesday's Pre-Market Session ↗

May 10, 2022

Gainers Vroom, Inc. (NASDAQ: VRM) shares rose 38% to $1.49 in pre-market trading after the company reported better-than-expected Q1 results.

Via Benzinga

90 Biggest Movers From Yesterday ↗

May 10, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 18, 2022

Gainers Natus Medical (NASDAQ:NTUS) stock rose 28.3% to $33.42 during Monday's pre-market session. The market value of their outstanding shares is at $1.1 billion....

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 14, 2022

Gainers

Via Benzinga

28 Stocks Moving in Monday's Pre-Market Session ↗

March 21, 2022

Gainers BitNile Holdings, Inc. (NYSE: NILE) rose 61.1% to $0.90 in pre-market trading. BitNile's TurnOnGreen resumed expansion of its electric vehicle charging network and e-...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 18, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 04, 2022

Gainers Statera BioPharma (NASDAQ:STAB) stock rose 23.6% to $0.9 during Friday's pre-market session. The company's market cap stands at $32.4 million. InVivo...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 03, 2022

Gainers SOC Telemed (NASDAQ:TLMD) shares increased by 338.2% to $2.82 during Thursday's pre-market session. The market value of their outstanding shares is at $284.5...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 31, 2022

Gainers Oncternal Therapeutics (NASDAQ:ONCT

Via Benzinga

51 Biggest Movers From Yesterday ↗

January 26, 2022

Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.